OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out MRK/  DE000ME3AQY9  /

Stuttgart
11/7/2024  9:56:47 AM Chg.+0.02 Bid1:13:22 PM Ask1:13:22 PM Underlying Strike price Expiration date Option type
3.88EUR +0.52% 3.90
Bid Size: 5,000		 3.94
Ask Size: 5,000		 Merck and Co Inc 59.5536 USD 12/31/2078 Call
TeleTrader 10/31 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 7/31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 7/30 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 7/17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
TeleTrader 7/1 US closes higher after data
GlobeNewswire 6/27 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 5/30 Monte Rosa Therapeutics Announces Leadership Team Promotions
TeleTrader 5/28 US markets turn to losses, Dow plunges 330 points
GlobeNewswire 5/28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 5/23 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 5/23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 5/16 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 5/8 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire 4/18 The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 4/9 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire 4/5 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 4/3 TOMI Environmental Solutions Receives Gold Safety Award from Highwire